ACHV · NASDAQ · Biotechnology

Achieve Life Sciences (ACHV)

Develops cytisinicline for nicotine dependence across smoking-cessation and vaping-cessation programs.

$8.16
After-hours close+0.03 (+0.37%)
At close$8.13(+0.99%)